Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients.
“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”
Tempus, a Chicago-based healthcare technology company, collaborated with Geisinger on the solution.
The new analysis, published in Circulation: Cardiovascular Interventions, focused on data from more than 600 patients who participated in the COAPT trial.
The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older.
The study’s authors explored data from more than 900 low-risk patients who participated in the PARTNER 3 trial.
The study included data from nearly 17 million adults who received treatment from 2005 to 2011. Researchers compared the stroke rates of patients with atrial fibrillation and those without it.
The study, published in the American Journal of Cardiology, shines new light on a significant health issue.
The International League Against Epilepsy and American Epilepsy Society formed a task force to investigate this new warning, sharing its findings in Epilepsia Open.
The team's deep neural network was trained on more than 1.6 million 12-lead ECGs.
According to a new study published in Circulation, ablation was associated with numerous benefits over standard drug therapy.
The authors assessed 17 popular energy drinks, sharing their analysis in Food and Chemical Toxicology.